In this Section

Fibroids/Heavy Bleeding

Elagolix Study

A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women

The My Fibroid Study (MyUFStudy.com) is evaluating an investigational medication to see if it may safely and effectively reduce bleeding during your period.

You may qualify to participate if you:

  • Are premenopausal, 18-51 years old
  • Have heavy periods
  • Have uterine fibroids*
  • Have monthly periods A previous diagnosis of uterine fibroids is not required to qualify for the study

 

If you qualify and decide to participate, you will receive all study-related care and study medication at no cost. You may be reimbursed for travel and other expenses.

Call the Clinical Research Center at 757-446-5808.  

A previous diagnosis of uterine fibroids is not required to qualify for the study.

This advertisement has been approved by the Eastern Virginia Medical School Institutional Review Board IRB# Pro00016350